THE VALUE OF A RADIOIMMUNOLOGICAL MONITORING IN CANCER-PATIENTS TREATED WITH INTERFERON-ALPHA

被引：0
|
作者：
BERNIER, J
REUTER, A
VRINDTSGEVAERT, Y
FRANCHIMONT, P
POUILLART, P
BRETAUDEAU, B
FALCOFF, E
MAGDELENAT, H
机构：
[1] NATL INST RADIOELEMENTS,FLEURUS,BELGIUM
[2] INST CURIE,MED SECT,F-75231 PARIS 05,FRANCE
[3] INST CURIE,INSERM,UNITE 196,F-75231 PARIS 05,FRANCE
来源：
BULLETIN DU CANCER | 1984年 / 71卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：405 / 411
页数：7
相关论文
共 50 条
  • [1] DECREASED THEOPHYLLINE (THP) CLEARANCE IN CANCER-PATIENTS TREATED WITH INTERFERON-ALPHA (IFN)
    SHEDLOFSKY, SI
    MCINTYRE, WJ
    ZANNIKOS, PN
    NEEFE, JR
    BLOUIN, RA
    [J]. HEPATOLOGY, 1991, 14 (04) : A276 - A276
  • [2] Antibodies to interferon-alpha in treated cancer patients: Incidence and significance
    McKenna, RM
    Oberg, KE
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (03): : 141 - 143
  • [3] AUGMENTED IMMUNITY IN CANCER-PATIENTS TREATED WITH ALPHA-INTERFERON
    NEEFE, JR
    SULLIVAN, JE
    AYOOB, M
    PHILLIPS, E
    SMITH, FP
    [J]. CANCER RESEARCH, 1985, 45 (02) : 874 - 878
  • [4] EFFECTS OF INTERFERON-ALPHA MONOTHERAPY ON HEPATIC DRUG-METABOLISM IN CANCER-PATIENTS
    ISRAEL, BC
    BLOUIN, RA
    MCINTYRE, W
    SHEDLOFSKY, SI
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (03) : 229 - 235
  • [5] SIMILAR BIOLOGICAL EFFECTS OF DIFFERENT LOW-DOSES OF INTERFERON-ALPHA IN CANCER-PATIENTS
    BILLARD, C
    DIEZ, RA
    FERBUS, D
    RAYNAUD, N
    DORVAL, T
    POUILLART, P
    NIELSEN, K
    FALCOFF, E
    [J]. BRITISH JOURNAL OF CANCER, 1987, 55 (06) : 677 - 679
  • [6] PHASE-I STUDY OF A COMBINATION OF RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    KURZROCK, R
    ROSENBLUM, MG
    QUESADA, JR
    SHERWIN, SA
    ITRI, LM
    GUTTERMAN, JU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1677 - 1683
  • [7] IMMUNOSUPPRESSIVE EFFECTS OF RECOMBINANT INTERFERON-ALPHA DURING LONG-TERM TREATMENT OF CANCER-PATIENTS
    TEICHMANN, JV
    SIEBER, G
    LUDWIG, WD
    RUEHL, H
    [J]. CANCER, 1989, 63 (10) : 1990 - 1993
  • [8] EMERGENCE AND DECAY OF THE HUMAN MX HOMOLOG IN CANCER-PATIENTS DURING AND AFTER INTERFERON-ALPHA THERAPY
    JAKSCHIES, D
    HOCHKEPPEL, H
    HORISBERGER, M
    DEICHER, H
    VONWUSSOW, P
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (03): : 305 - 312
  • [9] Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha
    Esuvaranathan, Kesavan
    Chiong, Edmund
    Thamboo, Thomas Paulraj
    Chan, Yiong Huak
    Kamaraj, Revathi
    Mahendran, Ratha
    Teh, Ming
    [J]. CANCER, 2007, 109 (06) : 1097 - 1105
  • [10] HYPERTRIGLYCERIDEMIA MAY BE SEVERE IN CML PATIENTS TREATED WITH INTERFERON-ALPHA
    PENARRUBIA, MJ
    STEEGMANN, JL
    LAVILLA, E
    CASADO, F
    REQUENA, MJ
    PICO, M
    ARRANZ, R
    FERNANDEZRANADA, JM
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (03) : 240 - 241
12345